The effects of estradiol on central serotonergic systems and its relationship to mood in women

Biological Research for Nursing

Volumn 9, Issue 2, 2007, Pages 147-160

  Lasiuk, G C ^a   Hegadoren, K M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Depression; Estrogens; Mood disorders; Serotonin; Steroid hormones

Indexed keywords

ESTRADIOL; SEROTONIN; SEROTONIN RECEPTOR;

AFFECT; ARTICLE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; MOOD DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

AFFECT; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MOOD DISORDERS; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 34548790655     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800407305600     Document Type: Article

References (89)

1. Agid, O., Shapira, B., Zislin, J., Ritsner, M., Hanin, B., Murad, H., et al. (1999). Environment and vulnerability to major psychiatric illness: A case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Molecular Psychiatry, 4 (2). 63-72.
2. Ahokas, A., Kaukoranta, J., Wahlbeck, K., & Aito, M. (2001). Estrogen deficiency in severe postpartum depression: Successful treatment with sublingual physiologic 17beta-estradiol: A preliminary study. Journal of Clinical Psychiatry, 62 (5). 332-336.
3. American Psychiatric Association. (1980). Diagnostic and Statistical Manual of Mental Disorders (3 rd ed.). Washington, DC: Author.
4. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4 th ed.). Washington, DC: Author.
5. Amsterdam, J., Garcia-Espana, F., Fawcett, J., Quitkin, F., Reimherr, F., Rosenbaum, J., et al. (1999). Fluoxetine efficacy in menopausal women with and without estrogen replacement. Journal of Affective Disorders, 55 (1). 11-17.
6. Azmitia, E.C., & Whitaker-Azmitia, P.M. (1995). Anatomy. Cell biology and maturation of the serotonergic system. Retrieved June 15, 2006, from http://www.acnp.org/g4/GN401000042/Ch042.html
7. Bao, A-M., Hestiantoro, A., Van Someren, E.J., Swaab, D., & Zhou, J-N. (2005). Colocalization of corticotropinreleasing hormone and oestrogen receptor in the paraventricular nucleus of the hypothalamus in mood disorders. Brain, 128 (Pt. 6). 1301-1313.
8. Becker, J.B. (1999). Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacology Biochemistry and Behavior, 64 (4). 803-812.
9. Birmaher, B., Ryan, N.D., Williamson, D.E., Brent, D.A., & Kaufman, J. (1996). Childhood and adolescent depression: A review of the past 10 years. Journal of the American Academy of Child & Adolescent Psychiatry, 35 (11). 1427-1439.
10. Broadhead, J.C., & Abas, M.A. (1998). Life events, difficulties and depression among women in an urban setting in Zimbabwe. Psychological Medicine, 28 (1). 29-38.
11. Browne, A., & Finkelhor, D. (1986). Impact of child sexual abuse: A review of the research. Psychological Bulletin, 99 (1). 66-77.
12. Bulun, S.E., & Adashi, E.Y. (2003). The physiology and pathology of the female reproductive axis. In P. Reed Larsen, H. M. Kronenberg, S. Melmed, & K. S. Polonsky (Eds.), Williams textbook of endocrinology (10 th ed., pp. 587-664). Philadelphia: Saunders.
13. Carr, B.R., & Bradshaw, K.D. (2006). Disorders of the ovary and female reproductive tract. In J. L. Jameson (Ed.), Harrison's endocrinology (pp. 203-223). New York: McGraw-Hill.
14. Clarke, P.A., Iranmanesh, A., Veldhuis, J.D., & Rogol, A.D. (1997). Comparison of pulsatile luteinizing hormone secretion between prepubertal children and young adults: Evidence from a mass/amplitude-dependent difference without gender or day/night contrasts. Journal of Clinical Endocrinology and Metabolism, 82 (9). 2950-2955.
15. Cutler, S.E., & Nolen-Hoeksema, S. (1991). Accounting for sex differences in depression through female victimization: Childhood sexual abuse. Sex Roles, 24 (7-8). 425-438.
16. Cutter, W.J., Craig, M., Norbury, R., Robertson, D.M., Whitehead, M., et al. (2003). In vivo effects of estrogen on human brain. Annals of the New York Academy of Sciences, 1007, 79-88.
17. Douma, S.L., Husband, C., O'Donnell, M.E., Barwin, B.N., & Woodend, A.K. (2005). Estrogen-related mood disorders: Reproductive life cycle factors. Advances in Nursing Science, 28 (4). 364-375.
18. Frye, C.A. (2006). An overview of oral contraceptives: Mechanism of action and clinical use. Neurology, 66, S29 - S36.
19. Gentile, S. (2005). The role of estrogen therapy in postpartum psychiatric disorders: An update. CNS Spectrum, 10 (12). 944-952.
20. Green, A.H. (1993). Child abuse, neglect and depression. In H. S. Koplewicz & E. Klass (Eds.), Depression in children and adolescents: Monographs in clinical pediatrics, Vol. 6 (pp. 55-62). Philadelphia: Harwood.
21. Glennon, R.A., Dukat, M., & Westkaemper, R.B. (1995). Serotonin receptor subtypes and ligands. Retrieved June 15, 2006, from http://www.acnp.org/g4/GN401000039/Ch039.html
22. Gregoire, A.J.P., Kumar, R., Everitt, B., Henderson, A.F., & Studd, J.W.W. (1996). Transdermal oestrogen for treatment of severe postnatal depression. Lancet, 347 (9006). 930-933, 918-919.
23. Halbreich, U., Rojansky, N., Palter, S., Tworek, H., Hissin, P., & Wang, K. (1995). Estrogen augments serotonergic activity in postmenopausal women. Biological Psychiatry, 37 (7). 434-441.
24. Harris, R.Z., Benet, L.Z., & Schwartz, J.B. (1995). Gender differences in pharmacokinetics and pharmacodynamics. Drugs, 50 (2). 222-239.
25. Imwalle, D.B., Gustafsson, J.A., & Rissman, E.F. (2005). Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiology of Behavior, 84 (1). 157-163.
26. Kalita, K., Szymczak, S., & Kaczmarek, L. (2005). Non-nuclear estrogen receptor β and α in the hippocampus of male and female rats. Hippocampus, 15 (3). 404-412.
27. Kendall, D.A., Stancel, G.M., & Enna, S.J. (1982). The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. Journal of Neuroscience, 2 (3). 354-360.
28. Kendler, K.S. (1998). Gender differences in genetic epidemiology of major depression. Journal of Gender-Specific Medicine, 1 (2). 28-31.
29. Kendler, K.S., Gardner, C.O., Neale, M.C., & Prescott, C.A. (2001). Genetic risk factors for major depression in men and women: Similar or different heritabilities and same or partly distinct genes? Psychological Medicine, 31 (4). 605-616.
30. Kendler, K.S., Gardner, C.O., & Prescott, C.A. (2002). Toward a comprehensive developmental model for major depression in women. American Journal of Psychiatry, 159 (7). 1133-1145.
31. Kendler, K.S., Karkowski, L.M., & Prescott, C.A. (1999). Causal relationship between stressful life events and the onset of major depression. American Journal of Psychiatry, 156, 837-841.
32. Kendler, K.S., Kessler, R.C., Neale, M.C., Heath, A.C., & Eaves, L.J. (1993). The prediction of major depression in women: Toward an integrated etiologic model. American Journal of Psychiatry, 150 (8). 1139-1148.
33. Kendler, K.S., Neale, M.C., Kessler, R.C., Heath, A.C., & Eaves, L.J. (1992). Childhood parental loss and adult psychopathology in women. A twin study perspective. Archives of General Psychiatry, 49 (2). 109-116.
34. Kessler, R.C., McGonagle, K.A., Nelson, C.B., Hughes, M., Swartz, M., & Blazer, D.G. (1994). Sex and depression in the National Comorbidity Survey. II: Cohort effects. Journal of Affective Disorders, 30 (1). 15-26.
35. Kuiper, G.G., Shughrue, P.J., Merchenthaler, I., & Gustafsson, J.A. (1998). The estrogen receptor beta subtype: A novel mediator of estrogen action in neuroendocrine systems. Frontiers in Neuroendocrinology, 19 (4). 253-286.
36. Kumar, C., McIvor, R.J., Davies, T., Brown, N., Papadopoulos, A., Wieck, A., et al. (2003). Estrogen administration does not reduce the rate of recurrence of affective psychosis after childbirth. Journal of Clinical Psychiatry, 64 (2). 112-118.
37. Kurshan, N. & Neill, E.C. (2006). Oral contraceptives and mood in women with and without premenstrual dysphoria: A theoretical model. Archives of Women's Mental Health, 9 (1). 1-14.
38. Laycock, J., & Wise, P. (1996). Essential endocrinology (3 rd ed.). Oxford, UK: Oxford University Press.
39. Lee, S.H., & Mouradian, M.M. (1999). Up-regulation of D1A dopamine receptor gene transcription by estrogen. Molecular and Cell Endocrinology, 156 (1-2). 151-157.
40. Le Saux, M., & Di Paolo, T. (2006). Influence of oestrogenic compounds on monoamine transporters in rat striatum. Journal of Neuroendocrinology, 18 (1). 25-32.
41. Lievertz, R. (1987). Pharmacokinetic and pharmacokinetics of estrogens. American Journal of Obstetrics and Gynecology, 156 (5). 1289-1293.
42. Loewenthal, K., Goldblatt, V., Gorton, T., Lubitsch, G., Bicknell, H., Fellowes, D., et al. (1995). Gender and depression in Anglo-Jewry. Psychological Medicine, 25 (5). 1051-1063.
43. Lu, N.Z., Shlaes, T.A., Gundlah, C., Dziennis, S.E., Lyle, R.E., & Bethea, C.L. (1999). Ovarian steroid action on tryptophan hydroxylase protein and serotonin compared to localization of ovarian steroid receptors in midbrain of guinea pigs. Endocrine, 11 (3). 257-267.
44. Maggi, A., Ciana, P., Belcredito, S., & Vegeto, E. (2004). Estrogens in the nervous system: Mechanisms and non-reproductive functions. Annual Review of Physiology, 66, 291-313.
45. Maharjan, S., Serova, L., & Sabban, E.L. (2005). Transcriptional regulation of tyrosine hydroxylase by estrogen: Opposite effects with estrogen receptors α and β and interactions with cyclic AMP. Journal of Neuro-chemistry, 93 (6). 1502-1514.
46. Malyala, A., Kelly, M.J., & Ronnekleiv, O.K. (2005). Estrogen modulation of hypothalamic neurons: Activation of multiple signalling pathways and gene expression changes. Steroids, 70 (5-7). 397-406.
47. Mavreas, V.G., Beis, A., Mouyias, A., Rigoni, F., & Lyketsos, G.C. (1986). Prevalence of psychiatric disorders in Athens: A community study. Social Psychiatry, 21 (4). 172-181.
48. McDonnell, D.P., Clemm, D.L., Hermann, T., Goldman, M.E., & Pike, J.W. (1995). Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Molecular Endocrinology, 9 (6). 659-669.
49. McEwen, B. (1999). The molecular and neuroanatomical basis for estrogen effects in the central nervous system. Journal of Clinical Endocrinology & Metabolism, 84 (6). 1790-1797.
50. McEwen, B.S., & Alves, S.E. (1999). Estrogen actions in the central nervous system. Endocrine Reviews, 20 (3). 279-307.
51. Murray, C.J., & Lopez, A.D. (1997). Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet, 349 (9063). 1436-1442.
52. Nomura, M., Akama, K.T., Alves, S.E., Korach, K.S., Gustafsson, J.A., et al. (2005). Differential distribution of estrogen receptor (ER)-alpha and ER-beta in the midbrain raphe nuclei and periaqueductal gray in male mouse: Predominant role of ER-beta in midbrain serotonergic systems. Neuroscience, 130 (2). 445-456.
53. Norman, R.J., Flight, I.H.K., & Rees, M.C.P. (2005). Oestrogen and progesterone hormone replacement therapy for peri-menopausal and post-menopausal women: Weight and body fat distribution. The Cochrane Library, (1). (ID #CD001018).
54. O'Connell, M. (1995). Pharmacokinetic and pharmacologic variations between different estrogen products. Journal of Clinical Pharmacology, 35 (Suppl.), 18S - 24S. Oinonen, K.A., & Mazmanian, D. (2002). To what extent do oral contraceptives influence mood and affect? Journal of Affective Disorders, 70 (3). 229-240.
55. Oppenheim, G. (1984). A case of rapid mood cycling with estrogen: Implications for therapy. Journal of Clinical Psychiatry, 45 (1). 34-35.
56. Palinkas, L.A., Russel, J., Downs, M.A., & Petterson, J.S. (1992). Ethnic differences in stress, coping, and depressive symptoms after the Exxon Valdez oil spill. Journal of Nervous and Mental Disease, 180 (5). 287-295.
57. Pandaranandaka, J., Poonyachoti, S., & Kalandakanond-Thongsong, S. (2006). Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats. Physiology & Behavior, 87 (4). 828-835.
58. Piccinelli, M., & Gomez-Homen, F. (1997). Gender differences in the epidemiology of affective disorders and schizophrenia. Geneva: World Health Organization, Division of Mental Health and Prevention of Substance Abuse. Prange, A.J. (1972). Estrogen may well affect response to antidepressant. Journal of the American Medical Association, 219, 143-144.
59. Rasgon, N.L., Altshuler, L.L., & Fairbanks, L. (2001). Estrogen-replacement therapy for depression. American Journal of Psychiatry, 158 (10). 1738.
60. Rasgon, N.L., Rao, R.C., Hwang, S., Altshuler, L.L., Elman, S., Zuckerbrow-Miller, J., et al. (2003). Depression in women with polycystic ovary syndrome: Clinical and biochemical correlates. Journal of Affective Disorders, 74 (3). 299-304.
61. Ressler, K.J., & Nemeroff, C.B. (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety, 12 (1, Suppl.). 2-19.
62. Ritsner, M., Ponizovsky, A., Nechamkin, Y., & Modai, I. (2001). Gender differences in psychosocial risk factors
63. Roberts, S.B., & Kendler, K.S. (1999). Neuroticism and self-esteem as indices of the vulnerability to major depression in women. Psychological Medicine, 29 (5). 1101-1109.
64. Robinson, S.A., Dowell, M., Pedulla, D., & McCauley, L. (2004). Do the emotional side-effects of hormonal contraceptives come from pharmacologic or psychological mechanisms ? Medical Hypotheses, 63 (2). 268-273.
65. Romans-Clarkson, S.E., Walton, V.A., Herbison, G.P., & Mullen, P.E. (1988). Marriage, motherhood and psychiatric morbidity in New Zealand. Psychological Medicine, 18 (4). 983-990.
66. Rubinow, D.R., Schmidt, P.J., & Roca, C.A. (1998). Estrogen-serotonin interactions: Implications for affective regulation. Biological Psychiatry, 44 (9). 839-850.
67. Rudolph, I., Palombo-Kinne, E., Kirsch, B., Mellinger, U., Breitbarth, H., & Graser, T. (2004). Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression. Climacteric, 7 (3). 301-311.
68. Schmidt, P.J., Nieman, L., Danaceau, M.A., Tobin, M.B., Roca, C.A., Murphy, J.H., et al. (2000). Estrogen replacement in perimenopause-related depression: A preliminary report. American Journal of Obstetrics and Gynecology, 183 (2). 414-420.
69. Schneider, L.S., Small, G.W., & Clary, C. (2001). Estrogen replacement therapy and antidepressant response to sertraline. American Journal of Geriatric Psychiatry, 9 (4). 393-399. Schneider, L.S., Small, G.W., Hamilton, S.H., Bystritsky, A., Nemeroff, C.B., & Meyers, B.S. (1997).
70. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. American Journal of Geriatric Psychiatry, 5 (2). 97-106.
71. Shapira, B., Oppenheim, G., Zohar, J., Segal, M., & Malach, D. (1985). Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biological Psychiatry, 20 (5). 576-579.
72. Sichel, D.A., Cohen, L.S., Robertson, L.M., Ruttenberg, A., & Rosenbaum, J.F. (1995). Prophylactic estrogen in recurrent postpartum affective disorder. Biological Psychiatry, 38 (12). 814-818.
73. Simpson, E.R., Zhao, Y., Agarwal, V.R., Michael, M.D., Bulun, S.E., Hinshelwood, M.M., et al. (1997). Aromatase expression in health and disease. Recent Progress in Hormone Research, 52, 185-213.
74. Slap, G.B. (1981). Oral contraceptives and depression: Impact, prevalence and cause. Journal of Adolescent Health Care, 2 (1). 53-64.
75. Soares, C.N., Almeida, O.P., Joffe, H., & Cohen, L.S. (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial. Archives of General Psychiatry, 58 (6). 529-534.
76. Stahl, S. (1998). Mechanism of action of serotonin selective reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects and side-effects. Journal of Affective Disorders, 51 (3). 215-235.
77. Stahl, S. (2000). Essential psychopharmacology: Neuroscientific basis and practical applications. New York: Cambridge University Press.
78. Tecott, L. (2000). Monoamine neurotransmitters. In V. Sadock & B. J. Sadock (Eds.), Kaplan & Sadock's comprehensive textbook of psychiatry (7 th ed., on CD-ROM). Philadelphia: Lippincott Williams & Wilkins.
79. Toran-Allerand, C.D. (2004). Estrogen and the brain: Beyond ER-α and ER-β. Experimental Gerontology, 39 (11-12). 1579-1586.
80. U.S. Pharmacist. (2000). The new science of estrogen receptors. U.S. Pharmacist Continuing Education. Retrieved June 15, 2006, from http://www.uspharmacist.com/NewLook/CE/er/lesson.htm
81. Ustan, T. (2000). Cross-national epidemiology of depression and gender. The Journal of Gender-Specific Medicine, 3 (2). 54-58.
82. Vazquez-Barquero, J.L., Diez-Manrique, J.F., Pena, C., Aldama, J., Samaniego-Rodriguez, C., Menendez Arango, J., et al. (1987). A community mental health survey in Cantabria: A general description of morbidity. Psychological Medicine, 17 (1). 227-241.
83. Veijola, J., Puukka, P., Lehtinen, V., Moring, J., Lindholm, T., & Vaisanen, E. (1998). Sex differences in the association between childhood experiences and adult depression. Psychological Medicine, 28 (1). 21-27.
84. Weissman, M.M., Bland, R.C., Canino, G.J., Faravelli, C., Greenwald, S., Hwu, H., et al. (1996). Cross-national epidemiology of major depression and bipolar disorder. Journal of the American Medical Association, 276 (4). 293-299.
85. Weissman, M.M., & Klerman, G.L. (1977). Sex differences and the epidemiology of depression. Archives of General Psychiatry, 34 (1). 98-111.
86. Wihlback, A.C., Sundstrom, P.I., Bixo, M., Allard, P., Mjorndal, T., & Spigset, O. (2004). Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding. Psychoneuroendocrinology, 29 (6). 757-766.
87. World Health Organization. (2000). Depression. Retrieved June 15, 2006, from http://www.who.int/mental_health/management/depression/definition/en/
88. Young, R.C., Moline, M., & Keyman, F. (1997). Hormone replacement therapy and late-life mania. American Journal of Geriatric Psychiatry, 5 (2). 179-181.
89. Zweifel, J.E., & O' Brien, W.H. (1997). A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology, 22 (3). 189-212.